107th IOC Session - LA84 Foundation
107th IOC Session - LA84 Foundation
107th IOC Session - LA84 Foundation
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Doping Control<br />
A comprehensive doping control programme<br />
was carried out to ensure fair competition<br />
and continue the fight against the use of<br />
performance-enhancing drugs in sports. The<br />
programme was implemented under the direction<br />
of the <strong>IOC</strong> Medical Commission in full accordance<br />
with the <strong>IOC</strong> Medical Code.<br />
To collect samples, doping control stations<br />
were set up at fifteen competition sites, at the<br />
Olympic Village Polyclinic, and at the medical<br />
clinic in the Satellite Village in Karuizawa.<br />
During the Games, a total of 206 doctors, clinical,<br />
nursing, and operations support staff worked<br />
in rotation to implement the drug testing programme.<br />
Testing was conducted at all events,<br />
and procedures regarding the number of athletes<br />
and test substances were established by the <strong>IOC</strong><br />
Medical Commission in cooperation with<br />
NAOC, with input from the International<br />
Federations. In total, 621 samples were collected<br />
and sent to the <strong>IOC</strong>-accredited laboratory located<br />
in Nagano City for analysis.<br />
To avoid potential confusion with the IFs,<br />
NAOC published a “Doping Control Format”, a<br />
practice that was first adopted at the Atlanta<br />
Games. This Doping Control Format outlined<br />
drug testing controls, and its contents were written<br />
in consultation with and signed by a representative<br />
of each IF. While this Doping Control<br />
Format was largely successful in avoiding confusion<br />
at the Nagano Games, it is recommended<br />
that a more comprehensive Format be adopted<br />
at future Games, including details of procedures,<br />
materials, and banned substances decided in<br />
consultation with the <strong>IOC</strong> Medical Commission.<br />
12. Accreditation, Security, and Medical Services<br />
Testing for<br />
performance-enhancing<br />
drugs<br />
293